Carebricks
Healthcare's system of action for building and deploying AI agents across clinical and operational workflows
Platform · HybridCompany source
Company profile
About BunkerHill Health
Bunkerhill Health is a healthcare AI company that has developed Carebricks, a comprehensive platform designed to serve as healthcare's system of action. The company enables clinical and operational teams within health systems to build and deploy AI agents that can reason across complex patient data and execute real-world actions at scale. Unlike fragmented AI solutions, Carebricks operates as an integrated system that analyzes patient records, imaging, and clinical documentation while taking automated actions directly within existing EHR workflows. The platform supports a wide range of use cases including identifying actionable clinical findings, improving case-mix accuracy, streamlining prior authorization, boosting preventive screening, preventing hospital infections, identifying clinical trial candidates, and automating registry mapping. Bunkerhill's technology includes FDA-cleared algorithms for detecting conditions such as coronary artery calcium and aortic valve calcium from routine chest CT scans. The platform operates with real-time read-and-write capabilities inside EHR systems, allowing workflows to run within existing clinical processes without requiring clinicians to manage additional systems. By driving the cost of experimentation and iteration toward zero, Carebricks enables health systems to rapidly translate clinical ideas into operational workflows that reduce manual work and improve patient care across multiple service lines, 24/7.
Company description BunkerHill Health official website
Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Work at BunkerHill Health?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Aortic valve stenosis
- Cancer (multiple types)
- COPD
- Coronary artery disease
- Diabetes
- Heart failure
- Hereditary cancer syndromes
- Hospital-acquired infections (CAUTI, CLABSI)
- Liver steatosis
- Pulmonary nodules
- Sepsis with acute kidney injury
Who it serves
- Academic Medical Centers
- Health Systems
- Hospital Networks
Deployment & integration
Hybrid deployment with recorded integration context.
Recorded integration context: Clinical imaging systems, EHR systems (real-time read-write capabilities), MyChart patient portals, Operational systems for referrals and orders.
Geographic context
MarketsUnited States
Company sourceOfficial website
Company milestones
Platform expansion
KLAS Research published Emerging Insights case study on UTMB Health deployment (March 2026). Multiple health system deployments across cardiology, pulmonology, oncology, infection prevention, and operational workflows. FDA clearance obtained for CAC and aortic valve calcium detection algorithms.
Partnerships
Recorded partners
- Endeavor Health
- HCA West Florida
- KLAS Research
- Stanford University (clinical research collaboration)
- UTMB Health
- WVU Medicine
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Advancing osteoporosis opportunistic screening: multicenter validation of a deep learning algorithm using abdominal CT scans.Abdominal radiology (New York) · May 1, 2026
Digital Twin Technology In Radiology.Journal of imaging informatics in medicine · Apr 1, 2026
A generalizable deep learning system for cardiac MRI.Nature biomedical engineering · Mar 25, 2026
Effects of Real-Time Notification of AI-Detected Incidental Coronary Artery Calcium on Statin Prescription: The NOTIFY-PICTURE Trial.Circulation · Jan 20, 2026
Pixel Tampering: Does Face Redaction Harm Medical AI Performance?Journal of imaging informatics in medicine · Dec 16, 2025
Teaching AI for Radiology Applications: A Multisociety-Recommended Syllabus from the AAPM, ACR, RSNA, and SIIM.Radiology. Artificial intelligence · Nov 1, 2025
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Bunkerhill Contrast CACK260166 · 510k · Mar 6, 2026
Bunkerhill Contrast AVCK260167 · 510k · Mar 6, 2026
Bunkerhill MACK250662 · 510k · Oct 3, 2025
Bunkerhill ECG-EFK250649 · 510k · Sep 19, 2025
Bunkerhill Abdominal Aortic Quantification (AAQ)K243779 · 510k · Jul 1, 2025
BunkerHill BMDK242295 · 510k · Apr 8, 2025
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
11.7% of routine chest CT patients identified with unaddressed clinically significant CAC
UTMB Health CAC detection program
80% faster lung nodule triage
UTMB Health
5.5% of routine chest CT patients identified for life-saving cardiac follow-ups
Endeavor Health
58% of chest CT scans with coronary calcium detected
HCA West Florida
7% of patients identified with undiagnosed CAC
WVU Medicine
100% of agentic workflows fully automated
UTMB Health deployment
20+ AI agents live
UTMB Health
7+ clinical domains using AI agents
UTMB Health
UTMB Health (University of Texas Medical Branch)
Systemwide AI-powered workflow automation across clinical and operational processes including coronary artery calcium detection, aortic valve calcium, incidental pulmonary nodules, liver steatosis, referral queue triage, prior authorization automation, and case mix optimization
20+ AI agents live, 7+ clinical domains using AI agents, 100% of agentic workflows fully automated, 11.7% of routine chest CT patients identified with unaddressed clinically significant CAC, 80% faster lung nodule triage
Endeavor Health
Identifying routine chest CT patients requiring life-saving cardiac follow-ups
5.5% of routine chest CT patients identified for life-saving cardiac follow-ups
HCA West Florida
Detecting coronary calcium in chest CT scans
58% of chest CT scans detected with coronary calcium
UTMB Health
Lung nodule triage workflow automation
80% faster lung nodule triage
WVU Medicine
Early detection of coronary artery disease through undiagnosed coronary artery calcium identification
7% of patients identified with undiagnosed CAC
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Nish Khandwala
CEO
Nish Khandwala
CEO
Peter McCaffrey
Chief AI Officer at UTMB Health (Customer)
Peter McCaffrey
Chief AI Officer at UTMB Health (Customer)
Alex Sandhu
MD, MS - Stanford University Cardiologist and Health Services Researcher (Featured Expert)
Alex Sandhu
MD, MS - Stanford University Cardiologist and Health Services Researcher (Advisor/Partner)
06 · Company updates
Updates from BunkerHill Health
Recent articles published on BunkerHill Health's official website.
Bunkerhill Health Named Winner in Newsweek's AI Impact Awards 2026 for Second Consecutive Year
Read on BunkerHill HealthHow Bunkerhill Health Secured CMS Reimbursement for Cardio AI
Read on BunkerHill HealthUTMB Health
Read on BunkerHill HealthRecognize Parkinsonian Features in Notes
Read on BunkerHill HealthHCA West Florida
Read on BunkerHill Health07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Cardiology & Cardiovascular Health
Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.